The ProM²OLIE cross-sectional project of the M²OLIE Forschungscampus involves an organisational scientific perspective of the molecular intervention process. The overarching aim of the project is to ensure the smooth and efficient overall operation of the various sub-processes of a molecular treatment of patients both during the research phase and during the subsequent actual operation by way of a holistic process management and an integrated approach. ProM²OLIE operationalises the goal of M²OLIE to treat the patient in a so-called "one-stop shop" within a few hours. In the envisaged one-stop shop, the patient goes through the process steps of diagnosis, analysis, preparation and intervention in one day.
To achieve the M²OLIE objective, the following measures are carried out:
In the preliminary phase of the M²OLIE Forschungscampus the cross-sectional project has modelled the future molecular intervention process and analysed it structurally and behaviourally. In this way, initial findings on the treatment duration, costs, technologies used, intervention methods, resources and personnel were obtained.
The main phase of the ProM²OLIE cross-sectional project addresses weaknesses and the successful implementation, testing and incremental refinement of molecular intervention processes in the experimental practice operation. The molecular intervention process includes all activities patients go through, from admission to release. This process also includes logistical sub-processes for material and drug flow, based on recent modelling and simulation techniques. Preliminary cost simulations have already been conducted. The result of these simulations has implications on the administrative efficiency analysis of the molecular intervention. Further results achieved by ProM²OLIE are among others the design, development and clinical evaluation of IT solutions targeted at the removal of critical shortages in the overall process. The cross-sectional project ProM²OLIE further aims to design process definitions and control mechanisms for the planning of resources, capacity and scheduling for an IT platform. This IT platform is developed as part of Cross-Sectional Project 2 M²PROCIT.
Patient-centred, transparent, economical and time-optimised clinical treatment pathways for tumour patients.
Prof. Dr. Armin Heinzl
Dr. Kai Spohrer
Dr. Ulrich Thiel
Universitätsklinikum Mannheim GmbH
Zoé I. Morgenstern
Prof. Dr. Armin Heinzl
University of Mannheim
2. Chair of General Management and Information Systems
L 15, 1-6 - Raum 515/516
Tel.: +49 621 181-1690
Dipl.-Inf. Sebastian Schöning
Project group for Automation in Medicine and Biotechnology PAMB
Tel.: +49 621 1720 7123